These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17713354)
1. Botulinum toxin therapy in the ovalbumin-sensitized rat. Wen WD; Yuan F; Wang JL; Hou YP Neuroimmunomodulation; 2007; 14(2):78-83. PubMed ID: 17713354 [TBL] [Abstract][Full Text] [Related]
2. Experimental studies for botulinum toxin type A on allergic rhinitis in the rat. Wen WD; Yuan F; Hou YP; Song YF Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 39(2):97-101. PubMed ID: 15195592 [TBL] [Abstract][Full Text] [Related]
3. Treatment of allergic rhinitis with intranasal infusion of botulinum toxin type A in mice. Aoishi K; Takahashi H; Hato N; Gyo K; Yokota M; Ozaki S; Suzuki M Life Sci; 2016 Feb; 147():132-6. PubMed ID: 26285171 [TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908 [TBL] [Abstract][Full Text] [Related]
5. [Experimental studies for botulinum toxin type A to antagonist the VIP/PACAP expression on nasal mucosa in allergic rhinitis rat]. Liu L; Wang B; Liang G; Lu L; Yang L Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(1):49-53. PubMed ID: 27197456 [TBL] [Abstract][Full Text] [Related]
6. An essential role for dendritic cells in human and experimental allergic rhinitis. KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic alteration of neuropeptide-containing nerve fibres in seasonal intermittent allergic rhinitis. Heppt W; Dinh QT; Cryer A; Zweng M; Noga O; Peiser C; Melvan M; Witt C; Fischer A; Groneberg DA Clin Exp Allergy; 2004 Jul; 34(7):1105-10. PubMed ID: 15248857 [TBL] [Abstract][Full Text] [Related]
8. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs. Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical and pathological study of capsaicin in the treatment of rabbit animal model with allergic rhinitis]. Zhang F; Han D; Zhu X Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 34(4):229-31. PubMed ID: 12764779 [TBL] [Abstract][Full Text] [Related]
10. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis. Han DM; Zhou B; Wang T; Wang XD; Fan EZ Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982 [TBL] [Abstract][Full Text] [Related]
11. Suppressive Activity of Adiponectin on the Development of Allergic Rhinitis in Mice. Furukawa S; Asano K; Kobayashi H In Vivo; 2019; 33(1):93-98. PubMed ID: 30587608 [TBL] [Abstract][Full Text] [Related]
12. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492 [TBL] [Abstract][Full Text] [Related]
13. [Expression of substance P receptor mRNA in nasal mucosa of rat in allergic rhinitis model]. Xue J; Zhao H; An Y; Liang A; Zhao C Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Aug; 35(4):247-50. PubMed ID: 12768696 [TBL] [Abstract][Full Text] [Related]
14. Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method. Chalastras T; Nicolopoulou-Stamati P; Patsouris E; Eleftheriadou A; Kandiloros D; Yiotakis I; Gonidi M; Athanassiadou P J Laryngol Otol; 2008 Jul; 122(7):700-6. PubMed ID: 18282334 [TBL] [Abstract][Full Text] [Related]
15. Effects of cryptoporus polysaccharide on rat allergic rhinitis associated with inhibiting eotaxin mRNA expression. Xie QM; Deng JF; Deng YM; Shao CS; Zhang H; Ke CK J Ethnopharmacol; 2006 Oct; 107(3):424-30. PubMed ID: 16765544 [TBL] [Abstract][Full Text] [Related]
16. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Ozcan C; Vayisoglu Y; Doğu O; Görür K Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174 [TBL] [Abstract][Full Text] [Related]
17. [Distribution of substance P receptors in rat nasal mucosa of allergic rhinitis]. An Y; Zhao C; Zhu Q Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 33(3):139-41. PubMed ID: 11717901 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo. Hou YP; Zhang YP; Song YF; Zhu CM; Wang YC; Xie GL Can J Physiol Pharmacol; 2007 Feb; 85(2):209-14. PubMed ID: 17487262 [TBL] [Abstract][Full Text] [Related]
19. Repeated intranasal instillation with staphylococcal enterotoxin B induces nasal allergic inflammation in guinea pigs. Tang X; Sun R; Hong S; Hu G; Yang Y Am J Rhinol Allergy; 2011; 25(3):176-81. PubMed ID: 21679529 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. Lucioni A; Bales GT; Lotan TL; McGehee DS; Cook SP; Rapp DE BJU Int; 2008 Feb; 101(3):366-70. PubMed ID: 18184328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]